Coronary artery tortuosity and mid-term all-cause mortality of patients with ischemia and non-obstructive coronary arteries

[1] VIRANI SS, ALONSO A, BENJAMIN EJ, BITTENCOURT MS, CALLAWAY CW, CARSON AP, et al. Heart disease and stroke statistics—2020 update a report from the American Heart Association. Circulation 2020;141:E139–596. Search in Google Scholar

[2] NAPP AE, HAASE R, LAULE M, SCHUETZ GM, RIEF M, DREGER H, et al. Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial. Eur Radiol 2017;27:2957–68. Search in Google Scholar

[3] BAIREY MERZ CN, SHAW LJ, REIS SE, BITTNER V, KELSEY SF, OLSON M, et al. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular cor. J Am Coll Cardiol 2006;47:S21–9. Search in Google Scholar

[4] PATEL MR, PETERSON ED, DAI D, BRENNAN JM, REDBERG RF, ANDERSON HV, et al. Low Diagnostic Yield of Elective Coronary Angiography. New England Journal of Medicine 2010;362:886–95. Search in Google Scholar

[5] LI Y, SHEN C, JI Y, FENG Y, MA G, LIU N. Clinical implication of coronary tortuosity in patients with coronary artery disease. PLoS One 2011;6:1–5. Search in Google Scholar

[6] HAN HC. Twisted blood vessels: Symptoms, etiology and biomechanical mechanisms. J Vasc Res 2012;49:185–97. Search in Google Scholar

[7] GUPTA A, PANDA P, SHARMA Y, MAHESH A, SHARMA P, MAHESH NK. Clinical Profile of Patients with Coronary Tortuosity and Its Relation with Coronary Artery Disease. Preprints.org 2018, 2018060381. Search in Google Scholar

[8] TURGUT O, YILMAZ A, YALTA K, YILMAZ BM, OZYOL A, KENDIRLIOGLU O, et al. Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation? Int J Cardiovasc Imaging 2007;23:671–7. Search in Google Scholar

[9] OEHLER AC, MINNIER J, LINDNER JR. Increased Coronary Tortuosity Is Associated with Increased Left Ventricular Longitudinal Myocardial Shortening. Journal of the American Society of Echocardiography 2017;30:1028-1034.e2. Search in Google Scholar

[10] NOEL BAIREY MERZ C, PEPINE CJ, WALSH MN, FLEG JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation 2017;135:1075–92. Search in Google Scholar

[11] ELEID MF, GUDDETI RR, TWEET MS, LERMAN A, SINGH M, BEST PJ, et al. Coronary artery tortuosity in spontaneous coronary artery dissection angiographic characteristics and clinical implications. Circ Cardiovasc Interv 2014;7:656–62. Search in Google Scholar

[12] CIURICĂ S, LOPEZ-SUBLET M, LOEYS BL, RADHOUANI I, NATARAJAN N, VIKKULA M, et al. Arterial Tortuosity. Hypertension 2019;73:951–60. Search in Google Scholar

[13] VISSEREN F, MACH F, SMULDERS YM, CARBALLO D, KOSKINAS KC, BÄCK M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227–337. Search in Google Scholar

[14] REGNAULT V, THOMAS F, SAFAR ME, OSBORNE-PELLEGRIN M, KHALIL RA, PANNIER B, et al. Sex difference in cardiovascular risk: Role of pulse pressure amplification. J Am Coll Cardiol 2012;59:1771–7. Search in Google Scholar

[15] NATOLI AK, MEDLEY TL, AHIMASTOS AA, DREW BG, THEARLE DJ, DILLEY RJ, et al. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 2005;46:1129–34. Search in Google Scholar

[16] GROVES SS, JAIN AC, WARDEN BE, GHARIB W, BETO RJ 2nd. Severe coronary tortuosity and the relationship to significant coronary artery disease. West Virginia Medical Journal 2009;105(4):14-7. Search in Google Scholar

[17] JAKOB M, SPASOJEVIC D, KROGMANN ON, WIHER H, HUG R, HESS OM. Tortuosity of Coronary Arteries in Chronic Pressure and Volume Overload. Cathet Cardiovasc Diagn 1996;38(1):25-31. Search in Google Scholar

[18] SANGHAVI M, RUTHERFORD JD. Cardiovascular physiology of pregnancy. Circulation 2014;130:1003–8. Search in Google Scholar

[19] XU X, WANG B, REN C, HU J, GREENBERG DA, CHEN T, et al. Age-related impairment of vascular structure and functions. Aging Dis 2017;8:590–610. Search in Google Scholar

[20] ESTRADA A, SOUSA AS, MESQUITA CT, VILLACORTA H. Coronary Tortuosity as a New Phenotype for Ischemia without Coronary Artery Disease. Arq Bras Cardiol 2022;119:883–90. Search in Google Scholar

[21] JONES E, ETEIBA W, MERZ NB. Cardiac Syndrome X and Microvascular Coronary Dysfunction. Trends Cardiovasc Med 2012;22:161–8. Search in Google Scholar

[22] MERZ CNB, PEPINE CJ. Syndrome X and microvascular coronary dysfunction. Circulation 2011;124:1477–80. Search in Google Scholar

[23] JANSEN TPJ, VAN KEEKEN K, KONST RE, DIMITRIU-LEEN A, MAAS AHEM, VAN ROYEN N, et al. Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries? Front Cardiovasc Med 2022;8:804731. Search in Google Scholar

[24] KONIGSTEIN M, BEN-YEHUDA O, REDFORS B, MINTZ GS, MADHAVAN M V., GOLOMB M, et al. Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 Trials. JACC Cardiovasc Interv 2021;14:1009–18. Search in Google Scholar

[25] ELLIS SG. Coronary Tortuosity and Long-Term Post-Stent Risk: What Is the Connection? JACC Cardiovasc Interv 2021;14:1019–20. Search in Google Scholar

[26] GAIBAZZI N, RIGO F, REVERBERI C. Severe coronary tortuosity or myocardial bridging in patients with chest pain, normal coronary arteries, and reversible myocardial perfusion defects. American Journal of Cardiology 2011;108:973–8. Search in Google Scholar

[27] LEVENT F, SENOZ O, EMREN SV, EMREN ZY, GEDIZ RB. Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis? Herz 2022;47:73–8. Search in Google Scholar

[28] KOLBITSCH T, LARBIG R, REDA S, BLASIUS A, PAAR V, WERNLY B, et al. P5136Coronary tortuosity is an indicator of poor controlled arterial hypertension and correlates with the severity of dyspnea in the absence of coronary artery disease. Eur Heart J 2018;39(Issue suppl_1):ehy566.P5136. Search in Google Scholar

[29] RUDNICKA AR, WELIKALA R, BARMAN S, FOSTER PJ, LUBEN R, HAYAT S, et al. Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke. Br J Ophthalmol 2022;106:1722–9. Search in Google Scholar

[30] LAM CSP, GAMBLE GD, LING LH, SIM D, LEONG KTG, YEO PSD, et al. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J 2018;39:1770–80. Search in Google Scholar

[31] CHOO EH, CHANG K, LEE KY, LEE D, KIM JG, AHN Y, et al. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries. J Am Heart Assoc 2019;8(14):e011990. Search in Google Scholar

[32] MGBEMENA O, ZHANG Y, VELARDE G. Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article. Cureus 2021;13(11):e19398. Search in Google Scholar

[33] LAUER MS, BLACKSTONE EH, YOUNG JB, TOPOL EJ. Cause of death in clinical research: Time for a reassessment? J Am Coll Cardiol 1999;34:618–20. Search in Google Scholar

[34] MORROW DA, WIVIOTT SD. Classification of Deaths in Cardiovascular Outcomes Trials Circulation. Circulation 2019;139:874–6. Search in Google Scholar